Artesunate Oral Product ( DrugBank: Artesunate )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
18脊髄小脳変性症(多系統萎縮症を除く。)1

18. 脊髄小脳変性症(多系統萎縮症を除く。)


臨床試験数 : 71 薬物数 : 101 - (DrugBank : 30) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 65
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04921930
(ClinicalTrials.gov)
July 1, 202131/5/2021Evaluation of the Effect of Artesunate in Friedreich Ataxia (FA)Evaluation of the Effect of Artesunate in Friedreich Ataxia (FA) Phase I-II Efficacy-Toxicity of Artesunate in Friedreich AtaxiaFriedreich AtaxiaDrug: Artesunate Oral ProductInstitut National de la Santé Et de la Recherche Médicale, FranceImagine InstituteNot yet recruiting16 Years65 YearsMale20Phase 1/Phase 2NULL